Science & Enterprise subscription

Follow us on Twitter

  • Statista this week released a chart showing consumer spending on wearable devices like smart watches is expected to… https://t.co/UFH8rNHnTI
    about 21 hours ago
  • New post on Science and Enterprise: Infographic – Big Wearables Spending Growth Expected https://t.co/LBbGRc2HEu #Science #Business
    about 21 hours ago
  • Three medical research studies using Apple iPhones and watches as data collection devices are now available for enr… https://t.co/kxUTVfZG7h
    about 2 days ago
  • New post on Science and Enterprise: Update – Enrollment Opens in Apple Medical Studies https://t.co/DfmESYz2Oo #Science #Business
    about 2 days ago
  • Many thanks @stonybrooku https://t.co/QCVs2hkb8T
    about 2 days ago

Please share Science & Enterprise

FDA Clearance Granted for Blood Tissue Monitor

Blood bag (NIH)

(National Institutes of Health)

Ornim Inc. in Santa Clarita, California said it received clearance from the U.S. Food and Drug Administration (FDA) to market its the CerOx 3210F monitor. The FDA action, known as a 510(k) clearance, is a pre-market notification required for medical devices to be sold in the U.S.

Ornim says the FDA action clears the CerOx 3210F monitor for use as a non-invasive monitor of blood flow in tissue of adults. The device has already been cleared for for non-invasive monitoring of regional hemoglobin oxygen saturation in the brain or skeletal muscle.

A 510(k) submission, named after the applicable section of FDA’s enabling legislation, demonstrates that the device to be marketed is at least as safe and effective — substantially equivalent — to a device that is already legally marketed. Submitters must compare their device to one or more similar legally marketed devices and make and support their substantial equivalency claims.

*     *     *

Please share Science & Enterprise ...
error

Comments are closed.